Home › NDC Lookup › RxCUI directory › RxCUI 2679499

0.5 ML benralizumab 20 MG/ML Prefilled Syringe — RxCUI 2679499

Name: 0.5 ML benralizumab 20 MG/ML Prefilled Syringe (RxCUI 2679499)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2679499 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2679499

Official name0.5 ML benralizumab 20 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbenralizumab 10 MG per 0.5 ML Prefilled Syringe; benralizumab 10 MG in 0.5 ML Prefilled Syringe

FDA products mapped3

Package NDCs mapped6

Reported Medicaid activity (SDUD)33,442 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Benralizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Fasenra is approved for three different conditions, not just asthma. It is used as an add-on treatment for severe eosinophilic asthma (a type of asthma driven by a specific inflamm...
What exactly is Fasenra treating — is it just for asthma?
No — Fasenra is a maintenance medication, not a rescue treatment. It works over time to prevent attacks, not to stop one that's already happening. Always keep your quick-relief inh...
Can I use Fasenra if I'm having an asthma attack?

📖 Read our full Benralizumab Injection guide →

🕸️ Concept Web — How 0.5 ML benralizumab 20 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.5 ML benralizumab 20 MG/ML Prefilled Syringe RxCUI 2679499 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Benralizumab 1989100 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Fasenra 1989105 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Benralizumab Prefilled Syringe 1989103 SCDF
- Benralizumab Injectable Product 1989102 SCDG
- Benralizumab Prefilled Syringe [Fasenra] 1989107 SBDF
- Fasenra Injectable Product 1989108 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Benralizumab 20 MG/ML 2679498 SCDC
- 0.5 ML benralizumab 20 MG/ML Prefilled Syringe [Fasenra] 2679502 SBD
- Benralizumab 20 MG/ML [Fasenra] 2679501 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Benralizumab 20 MG/ML SCDC · 2679498
Benralizumab Prefilled Syringe SCDF · 1989103
Benralizumab Injectable Product SCDG · 1989102

Brand-Name Concepts

0.5 ML benralizumab 20 MG/ML Prefilled Syringe [Fasenra] SBD · 2679502
Benralizumab 20 MG/ML [Fasenra] SBDC · 2679501
Benralizumab Prefilled Syringe [Fasenra] SBDF · 1989107
Fasenra Injectable Product SBDG · 1989108
Fasenra BN · 1989105

📦 FDA Products & Package NDCs

3 products · 6 package NDCs

6 package NDCs map to RxCUI 2679499 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00310-1730-30	1 SYRINGE, GLASS in 1 CARTON (0310-1730-30) / 1 mL in 1 SYR...	FASENRA	AstraZeneca Pharmaceuticals LP	2017-11-14
00310-1730-85	1 SYRINGE, GLASS in 1 CARTON (0310-1730-85) / 1 mL in 1 SYR...	FASENRA	AstraZeneca Pharmaceuticals LP	2017-11-14
00310-1745-01	1 CARTRIDGE in 1 CARTON (0310-1745-01) / .5 mL in 1 CARTRID...	FASENRA	AstraZeneca Pharmaceuticals LP	2024-06-03
00310-1745-95	1 CARTRIDGE in 1 CARTON (0310-1745-95) / .5 mL in 1 CARTRID...	FASENRA	AstraZeneca Pharmaceuticals LP	2024-06-03
00310-1830-30	1 CARTRIDGE in 1 CARTON (0310-1830-30) / 1 mL in 1 CARTRIDG...	FASENRA	AstraZeneca Pharmaceuticals LP	2019-10-04
00310-1830-85	1 CARTRIDGE in 1 CARTON (0310-1830-85) / 1 mL in 1 CARTRIDG...	FASENRA	AstraZeneca Pharmaceuticals LP	2019-10-04

Observed labelers: AstraZeneca Pharmaceuticals LP (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0517	Inj., benralizumab, 1 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.